Persistence of oral anticoagulant treatment for atrial fibrillation in the Netherlands: A surveillance study

BACKGROUND: In contrast to vitamin K antagonists (VKA), direct oral anticoagulants (DOAC's) are not strictly monitored and dose titrated by anticoagulation clinics in the Netherlands. This may affect drug persistence of atrial fibrillation (AF) patients, whom often require lifelong treatment. O...

Descripción completa

Detalles Bibliográficos
Autores principales: Zielinski, Gilda Denise, van Rein, Nienke, Teichert, Martina, Klok, Frederikus A., Rosendaal, Frits R., van der Meer, Felix J. M., Huisman, Menno V., Cannegieter, Suzanne C., Lijfering, Willem M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles: Thrombosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6971315/
https://www.ncbi.nlm.nih.gov/pubmed/31989096
http://dx.doi.org/10.1002/rth2.12261

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6971315/
https://www.ncbi.nlm.nih.gov/pubmed/31989096
http://dx.doi.org/10.1002/rth2.12261

Ejemplares similares